News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History
What is the current status of real-world evidence (RWE) in oncology? - ESMO
Photo from ESMO/LinkedIn
22/10/2023 17:36

What is the current status of real-world evidence (RWE) in oncology? - ESMO

ESMO (European Society for Medical Oncology) shared on LinkedIn:

“What is the current status of real-world evidence (RWE) in oncology?

According to a study presented at ESMO23, the number of publications on Real-World Evidence (RWE) in oncology has rapidly increased between 2020 and 2022, with Europe ranking second. The increase is noticeable also when looking at the abstracts submitted to ESMO23, where 50% of all submissions (4,580) were RWE studies. These data support the importance of the new ESMO-GROW guidance, which marks an important milestone towards improved accuracy in RWE reporting.”

For more details click here.
Source: ESMO/LinkedIn

cancer ESMO23 OncoDaily Oncology Real-World Evidence (RWE)
Blog
16:27 30/11/23
David Lubarsky: 4 Ms
Drugs
16:23 30/11/23
Mariana Brandao: My comment on the ARTEMIDE-01 phase I trial testing a new bispecific anti-PD-1/anti-TIGIT antibody called Rilvegostomig
Blog
16:18 30/11/23
Do you want to be part of the first-ever national cancer innovation accelerator initiative with public support from The White House? - CancerX Moonshot
Opinion
16:11 30/11/23
Gavin Preston: If thinking of going into medicine to get rich, forget it
Blog
16:04 30/11/23
Two charities will co-fund a major £5.5 million research programme called Stratified Medicine Paediatrics 2 - The Institute of Cancer Research
Blog
15:58 30/11/23
Aju Mathew: Rising numbers of hepatocellular carcinoma in India
Blog
15:51 30/11/23
Bente Mikkelsen: This is the latest edition of the IARC handbook series and covers the topic of oral cancer prevention
Blog
15:43 30/11/23
Rebekka K. Schneider: Our research will be supported by an European Research Council (ERC) consolidator grant
Blog
15:39 30/11/23
Otilia Ciobanu: Review on the potential of targeting the subventricular zone for improved outcomes in high-grade gliomas
Blog
15:33 30/11/23
Andre Lopes Carvalho: I had the incredible opportunity to celebrate the 20th anniversary of ZORA
Drugs
15:29 30/11/23
David Steensma: Randomized STIMULUS-MDS1 trial didn't meet endpoint
Blog
15:25 30/11/23
Monica M. Bertagnolli: One of my priorities is ensuring all people are represented in clinical trials
Insight
Positive
Societies
Career